Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral FMT Capsules for Decolonization of CRE
NCT05981430Not yet recruiting
- Sponsor
- The University of Hong Kong
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, double-blind trial of Fecal Microbiota Transplantation capsules in Enterobacteriaceae infection (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Carbapenem-resistant Enterobacteriaceae clearance rate at 1 month. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
Enterobacteriaceae infection
Beyond the preview
Go deeper on NCT05981430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05981430.